FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ORMDL3-PPP1R1B

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ORMDL3-PPP1R1B
FusionPDB ID: 61712
FusionGDB2.0 ID: 61712
HgeneTgene
Gene symbol

ORMDL3

PPP1R1B

Gene ID

94103

84152

Gene nameORMDL sphingolipid biosynthesis regulator 3protein phosphatase 1 regulatory inhibitor subunit 1B
Synonyms-DARPP-32|DARPP32
Cytomap

17q21.1

17q12

Type of geneprotein-codingprotein-coding
DescriptionORM1-like protein 3protein phosphatase 1 regulatory subunit 1Bdopamine and cAMP-regulated neuronal phosphoprotein 32
Modification date2020032920200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000304046, ENST00000394169, 
ENST00000579695, ENST00000582052, 
ENST00000584220, 
ENST00000394265, 
ENST00000394267, ENST00000254079, 
ENST00000579000, ENST00000580825, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 6 X 4=14417 X 10 X 9=1530
# samples 726
** MAII scorelog2(7/144*10)=-1.04064198449735
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(26/1530*10)=-2.55694812455156
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ORMDL3 [Title/Abstract] AND PPP1R1B [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ORMDL3 [Title/Abstract] AND PPP1R1B [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ORMDL3(38080283)-PPP1R1B(37785423), # samples:2
Anticipated loss of major functional domain due to fusion event.ORMDL3-PPP1R1B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ORMDL3-PPP1R1B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ORMDL3-PPP1R1B seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgenePPP1R1B

GO:0032515

negative regulation of phosphoprotein phosphatase activity

10807923



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:38080283/chr17:37785423)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ORMDL3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PPP1R1B (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000304046ORMDL3chr1738080283-ENST00000580825PPP1R1Bchr1737785423+98331441847268
ENST00000304046ORMDL3chr1738080283-ENST00000254079PPP1R1Bchr1737785423+160931441847268
ENST00000304046ORMDL3chr1738080283-ENST00000579000PPP1R1Bchr1737785423+150631441748235
ENST00000394169ORMDL3chr1738080283-ENST00000580825PPP1R1Bchr1737785423+2338166914952202235
ENST00000394169ORMDL3chr1738080283-ENST00000254079PPP1R1Bchr1737785423+2964166914952202235
ENST00000394169ORMDL3chr1738080283-ENST00000579000PPP1R1Bchr1737785423+2861166914952103202

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000304046ENST00000580825ORMDL3chr1738080283-PPP1R1Bchr1737785423+0.0103934830.98960644
ENST00000304046ENST00000254079ORMDL3chr1738080283-PPP1R1Bchr1737785423+0.0075766240.9924233
ENST00000304046ENST00000579000ORMDL3chr1738080283-PPP1R1Bchr1737785423+0.0074068450.9925931
ENST00000394169ENST00000580825ORMDL3chr1738080283-PPP1R1Bchr1737785423+0.0080734470.99192655
ENST00000394169ENST00000254079ORMDL3chr1738080283-PPP1R1Bchr1737785423+0.0055319140.9944681
ENST00000394169ENST00000579000ORMDL3chr1738080283-PPP1R1Bchr1737785423+0.0057264850.9942735

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ORMDL3-PPP1R1B

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ORMDL3chr1738080283PPP1R1Bchr1737785423166958PVVWTLTNLIHNMIRRRRPTPAMLFR
ORMDL3chr1738080283PPP1R1Bchr173778542331491PVVWTLTNLIHNMIRRRRPTPAMLFR

Top

Potential FusionNeoAntigen Information of ORMDL3-PPP1R1B in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Potential FusionNeoAntigen Information of ORMDL3-PPP1R1B in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ORMDL3-PPP1R1B_38080283_37785423.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-0303LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1102TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1102LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1102TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1102NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1103TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1103LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1103TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1111TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1114TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1114LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1116TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1116LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1116TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1116NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1120TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1120LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1121TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1121LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1121TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1121NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1136TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1136LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1136TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1136NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1141TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1148TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1148LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1148TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1155TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1155LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1157TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1159TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1159LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1159TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1163TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1163LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1163TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1165TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1165LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1165TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1165NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1168TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1168LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1170TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1170LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1170TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1170NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1176TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1176LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1176TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1185TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1185LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1185TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1186TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1186LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1186TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1186NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1192TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1192LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1301TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1301LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1301TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1301NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1302TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1302LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1304TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1308TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1308LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1308TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1309TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1315TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1315LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1315TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1315NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1316TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1316LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1316TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1316NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1317TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1317LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1317TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1317NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1319TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1319LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1319TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1319NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1320TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1320LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1320TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1320NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1322TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1322LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1322TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1322NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1323TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1323LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1324TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1324LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1324TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1327TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1327LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1327TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1327NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1329TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1329LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1334TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1334LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1335TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1335LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1335TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1335NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1336TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1339TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1339LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1341TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1341LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1343TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1351TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1351LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1351TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1351NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1352TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1352LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1352TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1352NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1353TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1353LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1353TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1353NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1357TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1357LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1357TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1357NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1359TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1359LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1359TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1359NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1361TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1361LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1361TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1361NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1363TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1364TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1364LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1364TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1364NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1368TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1368LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1368TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1368NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1369TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1369LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1369TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1369NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1370TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1370LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1370TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1371TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1371LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1371TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1371NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1372TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1372LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1372TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1373TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1373LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1374TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1374LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1376TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1376LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1378TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1378LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1378TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1378NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1379TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1379LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1379TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1379NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1380TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1380LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1380TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1380NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1383TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1383LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1383TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1383NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1384TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1384LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1384TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1387TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1387LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1387TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1387NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1391TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1391LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1391TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1391NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1392TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1392LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1392TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1392NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1393TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1396TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1396LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1397TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1397LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1398TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1398LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1398TLTNLIHNMIRRRRP419
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1398NLIHNMIRRRRPTPA722
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1399TNLIHNMIRRRRPTP621
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1399LTNLIHNMIRRRRPT520
ORMDL3-PPP1R1Bchr1738080283chr1737785423314DRB1-1412TNLIHNMIRRRRPTP621

Top

Fusion breakpoint peptide structures of ORMDL3-PPP1R1B

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ORMDL3-PPP1R1B

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score

Top

Vaccine Design for the FusionNeoAntigens of ORMDL3-PPP1R1B

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ORMDL3-PPP1R1Bchr1738080283chr1737785423419TLTNLIHNMIRRRRPACCCTCACCAACCTCATTCACAACATGATCCGGCGCAGGAGACCA
ORMDL3-PPP1R1Bchr1738080283chr1737785423520LTNLIHNMIRRRRPTCTCACCAACCTCATTCACAACATGATCCGGCGCAGGAGACCAACG
ORMDL3-PPP1R1Bchr1738080283chr1737785423621TNLIHNMIRRRRPTPACCAACCTCATTCACAACATGATCCGGCGCAGGAGACCAACGCCT
ORMDL3-PPP1R1Bchr1738080283chr1737785423722NLIHNMIRRRRPTPAAACCTCATTCACAACATGATCCGGCGCAGGAGACCAACGCCTGCC

Top

Information of the samples that have these potential fusion neoantigens of ORMDL3-PPP1R1B

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample

Top

Potential target of CAR-T therapy development for ORMDL3-PPP1R1B

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneORMDL3chr17:38080283chr17:37785423ENST00000304046-2422_4258154.0TransmembraneHelical
HgeneORMDL3chr17:38080283chr17:37785423ENST00000394169-4622_4258154.0TransmembraneHelical
HgeneORMDL3chr17:38080283chr17:37785423ENST00000579695-2422_4258154.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ORMDL3-PPP1R1B

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ORMDL3-PPP1R1B

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource